Evidence map›Paper›PMID 38720760›Full record

ArticleHeliyon2024

The preventive effects of

Fatemeh Babaei, Ava Navidi-Moghaddam, Ariyan Naderi, Shiva Ghafghazi, Mohammadreza Mirzababaei, Leila Dargahi, Ghazaleh Mohammadi, Marjan Nassiri-Asl

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Fatemeh BabaeiNeuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Ava Navidi-MoghaddamSchool of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Ariyan NaderiSchool of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Shiva GhafghaziDepartment of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mohammadreza MirzababaeiDepartment of Clinical Biochemistry, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Leila DargahiNeuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Ghazaleh MohammadiCellular and Molecular Research Center, Research Institute for Prevention of Non- Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran.
Marjan Nassiri-AslDepartment of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The brain is sensitive to oxidative stress, which can trigger microglial activation and neuroinflammation. Antioxidant therapies may provide neuroprotection against oxidative stress. In recent years antioxidant effects of probiotics and their possible mechanisms in oxidative stress-related models have been determined. In the current study, for the first time, we assessed the effects of

Indexed as

AntioxidantsGut microbiotaLipopolysaccharideOxidative stressSaccharomyces boulardii

Identifiers

PMID38720760
PMCPMC11076963

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.